September 15 2009  |  News Article 

Nucletron exclusive distributor of Isodose Control products 

Isodose Control and Nucletron join forces to drive innovation of high-precision cancer treatment, or brachytherapy. In this global partnership Nucletron leads all marketing, sales and service related activities, worldwide for both companies. Isodose Control will focus purely on development of innovative solutions.

“This combination makes us the undisputed global leader in brachytherapy, which offers safe and effective radiation treatment for the most frequently occurring kinds of cancer,’’ said Jos Lamers, CEO of Nucletron BV.

Providing meaningful solutions and options in treating cancer, so that patients may achieve longer and fuller lives, is a key challenge for all involved in cancer care. The two companies sign up to the challenge.

Eric van’t Hooft, founder of both Isodose Control BV and Nucletron BV is looking forward to speeding up market introductions: ” We want healthcare institutions and their patients to benefit from our  ideas as quickly as possible. We can now focus on bringing our innovative products to market even faster.”

All questions related to the Nucletron or Isodose Control solutions, such as product or price information, maintenance or user-related questions should now be addressed to the Nucletron staff. They are dedicated to support you with any question you may have. Please contact your nearest Nucletron representative for more information.

About Nucletron
Nucletron is a global leader in Radiation Oncology, working with clinical teams to realize innovative solutions that improve patient care. Nucletron strives to offer the best possible choice of radiation modalities through integrated products, software and services. Critical to the Nucletron philosophy is the establishment of close working relationships with individual clinical teams – reconfiguring traditional boundaries between customer and solution provider. Many Nucletron employees have clinical experience delivering oncology care, providing an in-depth understanding of the complex needs of clinicians.

About Isodose Control
Isodose Control, headquartered in Ede, the Netherlands, is an innovation-led medical technology company that specializes in developing next generation brachytherapy solutions. Together with oncologists and scientists world-wide, Isodose Control works continuously to improve brachytherapy techniques, in order to provide cancer treatment centres with the most refined and patient-friendly treatment techniques for their patients.